Effects of Placenta-Derived Mesenchymal Stem Cells on the Particulate Matter-Induced Damages in Human Middle Ear

So Young Kim1, Seung Ha Oh2, Jun Ho Lee2

  • 1Department of Otorhinolaryngology-Head & Neck Surgery, CHA University College of Medicine, Republic of Korea.

Stem Cells International
|December 10, 2019
PubMed

Insights

Placenta-derived mesenchymal stem cells (PL-MSCs) reduce inflammation in human middle ear epithelial cells (HMEECs) exposed to particulate matter (PM). PL-MSCs secrete anti-inflammatory factors like PGE2, TGF-β, and VEGF, reversing PM-induced inflammatory responses.

Area of Science:

  • Regenerative Medicine
  • Cell Biology
  • Environmental Health

Background:

  • Particulate matter (PM) exposure can induce inflammation in human middle ear epithelial cells (HMEECs).
  • Mesenchymal stem cells (MSCs) show potential therapeutic properties.
  • Placenta-derived mesenchymal stem cells (PL-MSCs) are a promising source for regenerative medicine.

Purpose of the Study:

  • To investigate the therapeutic effects of PL-MSCs on PM-induced inflammation in HMEECs.
  • To identify the key mediators involved in the anti-inflammatory action of PL-MSCs.

Main Methods:

  • HMEECs were exposed to PM (300 μg/ml) for 24 hours.
  • PM-treated HMEECs were co-cultured with PL-MSCs.
  • Gene expression of inflammatory (TNFα, COX2, IL1β, IL6, MUC5B) and anti-inflammatory (PTGES, TGFβ, VEGF) markers was analyzed using qRT-PCR.
  • PGE2 levels in culture media were measured via ELISA.

Main Results:

  • PM exposure significantly increased inflammatory gene expression in HMEECs.
  • Co-culture with PL-MSCs significantly reduced the expression of inflammatory genes (MUC5B, TNFα, IL1β, IL6) in PM-treated HMEECs.
  • PL-MSCs exhibited elevated expression of anti-inflammatory genes (PGE2, TGFβ, VEGF) and increased PGE2 secretion when co-cultured with PM-treated HMEECs.
  • PL-MSCs effectively reversed PM-induced inflammatory responses in HMEECs.

Conclusions:

  • PL-MSCs possess significant anti-inflammatory properties against PM-induced damage in HMEECs.
  • The anti-inflammatory effects of PL-MSCs are mediated by the secretion of PGE2, TGF-β, and VEGF.
  • PL-MSCs represent a potential therapeutic strategy for managing middle ear inflammation caused by environmental pollutants.